Tci Gene (ROCO:6879) Other Current Receivables: NT$0.0 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:6879 Tci Gene Inc ROCO:6879
64 GF Score
Price NT$34.00
GF Value NT$48.63
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Tci Gene Other Current Receivables?

Tci Gene ROCO:6879 64 Other Current Receivables is NT$0.0 Mil as of Dec. 2025. GuruFocus rates ROCO:6879 with a GF Score™ of 64/100 and a GF Value™ of NT$48.63 (Possible Value Trap). The stock has 5 warning signs investors should review.

Tci Gene's Other Current Receivables for the quarter that ended in Dec. 2025 was NT$0.0 Mil.

Tci Gene's quarterly Other Current Receivables declined from Dec. 2024 (NT$9.15 Mil) to Jun. 2025 (NT$0.27 Mil) but then stayed the same from Jun. 2025 (NT$0.27 Mil) to Dec. 2025 (NT$0.01 Mil).

Tci Gene's annual Other Current Receivables increased from Dec. 2023 (NT$0.00 Mil) to Dec. 2024 (NT$9.15 Mil) but then declined from Dec. 2024 (NT$9.15 Mil) to Dec. 2025 (NT$0.01 Mil).

Tci Gene Other Current Receivables Related Terms

Tci Gene Other Current Receivables Historical Data

* Premium members only.

The historical data trend for Tci Gene's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tci Gene Other Current Receivables Chart

Tci Gene Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Receivables
Get a 7-Day Free Trial 0.28 1.65 0.00 9.15 0.01

Tci Gene Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 9.15 0.27 0.01
ROCO:6879
64GF Score
Tci Gene Inc ROCO:6879
Other Current Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Tci Gene Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

What does a Other Current Receivables of NT$0.0 Mil mean?
Tci Gene (ROCO:6879) has a Other Current Receivables of NT$0.0 Mil as of Dec. 2025. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Tci Gene and its competitors.
Is Tci Gene's Other Current Receivables too high?
Tci Gene's current Other Current Receivables is NT$0.0 Mil. Overall, Tci Gene has a GF Score™ of 64/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Tci Gene's Other Current Receivables compare to VRTX and REGN?
Tci Gene's Other Current Receivables of NT$0.0 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Receivables for a Biotechnology company?
A good Other Current Receivables depends on the Biotechnology industry context. However, Other Current Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Receivables mean?
A high Other Current Receivables can signal that a stock is expensive relative to its fundamentals. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Tci Gene and its competitors. Tci Gene's current Other Current Receivables is NT$0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tci Gene stock overvalued right now?
Based on GuruFocus' analysis, Tci Gene (ROCO:6879) is currently considered Possible Value Trap. The stock's GF Value™ is NT$48.63, compared to a current price of NT$34.00 — trading 30.1% below its estimated fair value. The current Other Current Receivables is NT$0.0 Mil. Tci Gene's overall GF Score™ is 64/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Receivables calculated?
Other Current Receivables is calculated from a company's financial statements. For Tci Gene (ROCO:6879), the current Other Current Receivables is NT$0.0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Tci Gene (ROCO:6879) Overvalued in 2026?

Based on GuruFocus' analysis, Tci Gene stock appears to be undervalued. The current stock price of NT$34.00 is trading 30.1% below its estimated GF Value™ of NT$48.63. GuruFocus considers Tci Gene to be Possible Value Trap.

Key valuation signals for ROCO:6879:

  • Other Current Receivables: NT$0.0 Mil
  • GF Value™: NT$48.63 vs. price of NT$34.00 (30.1% below fair value)
  • GF Score™: 64/100 with 5 warning signs

No single metric tells the full story. See the ROCO:6879 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Tci Gene Business Description

Address No. 185-1, Gangqian Road, 10th FLoor, Neihu District, Taipei, TWN
Tci Gene Inc provides precision preventive medicines in Taiwan. It is the first to introduce the concept of precision preventive medicine with Predict prediction, Prevent prevention, and Personal Treatment personalized health management measures.
64GF Score

Get the complete analysis for ROCO:6879

Other Current Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$34.00
Price
NT$48.63
GF Value